Status:
TERMINATED
The Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP)
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Childhood Chronic Immune Thrombocytopenia
Eligibility:
All Genders
1-18 years
Phase:
PHASE2
PHASE3
Brief Summary
Immune thrombocytopenia (ITP) is an autoimmune disorder manifested as isolated low platelet count which results in a tendency for bleeding. Around 10% of childhood ITP does not reach resolution within...
Eligibility Criteria
Inclusion
- 1\. Children (\< 18 years) diagnosed with chronic ITP; \>1 year after a first diagnosis and baseline platelet count \< 30,000. The diagnosis of ITP will be the responsibility of the Pediatric Hematology specialist in each participating center.
- \-
Exclusion
- 1\. Children with thrombocytopenia due to other causes. 2. Refusal of child or guardian to participate.
- \-
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT01226524
Start Date
February 1 2011
End Date
August 1 2014
Last Update
August 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91120